Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INTERFERON BETA for Pineal parenchymal neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where INTERFERON BETA was used for Pineal parenchymal neoplasm malignant.

Most Reported Side Effects for INTERFERON BETA

Side Effect Reports % Deaths Hosp.
Off label use 95 35.7% 8 64
Eosinophilia 46 17.3% 0 45
Pruritus 30 11.3% 1 28
Rash maculo-papular 27 10.2% 0 27
Drug ineffective 26 9.8% 2 8
Multiple sclerosis relapse 26 9.8% 0 6
Rash 24 9.0% 1 22
Dizziness 23 8.7% 0 8
Pyrexia 21 7.9% 2 14
Ataxia 15 5.6% 0 0
Central nervous system lesion 15 5.6% 0 0
Gait disturbance 15 5.6% 0 5
Insomnia 15 5.6% 0 2
Anxiety 14 5.3% 0 1
Fall 14 5.3% 0 2

Other Indications for INTERFERON BETA

Covid-19 pneumonia (52) Multiple sclerosis (48) Covid-19 (43) Product used for unknown indication (33) Relapsing-remitting multiple sclerosis (25) Chronic hepatitis c (13) Hepatitis c (5)

Other Drugs Used for Pineal parenchymal neoplasm malignant

TEMOZOLOMIDE (29) VINCRISTINE (13) CARBOPLATIN (12) NIMUSTINE (10) CISPLATIN (7) ETOPOSIDE (7) THALIDOMIDE (5) TOPOTECAN (5)

Related Pages

INTERFERON BETA Full Profile All Pineal parenchymal neoplasm malignant Drugs INTERFERON BETA Demographics INTERFERON BETA Timeline